ORMP — Oramed Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Oramed Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 August 31st	2021 August 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	39.9	94.1	156	162	142
Prepaid Expenses
Total Current Assets	40.5	95.3	157	163	143
Net Property, Plant And Equipment	0.174	0.93	1.8	1.57	1.11
Long Term Investments
Other Long Term Assets
Total Assets	44.6	128	162	221	155
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.54	6.68	5.75	53.2	5.68
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	11.8	12.2	9.83	56.7	9.01
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	32.9	116	152	164	146
Total Liabilities & Shareholders' Equity	44.6	128	162	221	155
Total Common Shares Outstanding